Sign inJoin waitlistJoin the waitlist

AL

Alexandria Lee

Credentials: ·

History

University of California
2022–2025
Medical School
2018–2022

Research

From preclinical efficacy to 2022 (36.7 months median follow -up) updated CROWN trial, lorlatinib is the preferred 1st-line treatment of advanced ALK+ NSCLC
Review · Critical Reviews in Oncology/Hematology · 2023 · 21 citations
CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC
Lung Cancer · 2023 · First of 2 authors · 14 citations
CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code
Lung Cancer · 2023 · 8 citations

SO
Sai-Hong I Ou
11 papers
MN
Misako Nagasaka
7 papers
CP
Cathleen Park
2 papers · 2 as a fellow
Zhaohui Arter
2 papers · 2 as a fellow
Aaron Lisberg
1 paper
LC
Lanyi Chen
1 paper · 1 as a fellow
SZ
Shannon Zhang
1 paper · 1 as a fellow